Steven Marotta
Stock Analyst
(n/a)
# 1,581
Out of 4,648 analysts
15
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $29.90 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $44.87 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $5.21 | +437.94% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $22.46 | +82.59% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $29.17 | -0.58% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $106.66 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $26.39 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $29.90
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $44.87
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $5.21
Upside: +437.94%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $22.46
Upside: +82.59%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $29.17
Upside: -0.58%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $106.66
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $26.39
Upside: -